0001127602-20-024721.txt : 20200903 0001127602-20-024721.hdr.sgml : 20200903 20200903171755 ACCESSION NUMBER: 0001127602-20-024721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200903 DATE AS OF CHANGE: 20200903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCDONNELL MICHAEL R CENTRAL INDEX KEY: 0001121897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 201159978 MAIL ADDRESS: STREET 1: C/O IQVIA HOLDINGS INC. STREET 2: 83 WOOSTER HEIGHTS ROAD CITY: DANBURY STATE: CT ZIP: 06810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-09-01 0000875045 BIOGEN INC. BIIB 0001121897 MCDONNELL MICHAEL R 225 BINNEY STREET CAMBRIDGE MA 02142 1 EVP, Chief Financial Officer Restricted Stock Unit 0 2020-09-01 4 A 0 8045 0 A 2023-09-01 Common Stock 8045 8045 D Restricted Stock Unit 0 2020-09-01 4 A 0 16090 0 A 2023-09-01 Common Stock 16090 16090 D The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date]). /s/ Suzanne Murray, Attorney in Fact for Michael R. McDonnell 2020-09-03